Journal
NEUROREPORT
Volume 14, Issue 4, Pages 565-568Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00001756-200303240-00007
Keywords
CBP; histone acetyltransferase; huntingtin; Huntington's disease; PC12; polyglutamine
Categories
Funding
- NINDS NIH HHS [NS34144, NS34172, NS38377, NS16375] Funding Source: Medline
Ask authors/readers for more resources
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by the abnormal expansion of a polyglutamine tract in the huntingtin protein. We have developed PC12 cell lines in which the expression of an N-terminal truncation of huntingtin (N63) with either wild type (23Q) or expanded polyglutamine (148Q) can be induced by the removal of doxycycline. Differentiated PC12 cells induced to express N63-148Q showed cellular toxicity reaching up to 50% at 6 days post-induction. Histone acetyltransferase (HAT) activity and global histone acetylation was significantly decreased in cells expressing truncated huntingtin with mutant but not normal huntingtin. These data suggest that altered chromatin modification via reduction in coactivator activity may cause neuronal transcriptional dysregulation and contribute to cellular toxicity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available